Clinical studies recruiting near Chengde

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Phase 1/Phase 2 · Affiliated Hospital of Chengde Medical University · Chipscreen Biosciences, Ltd. · NCT07129382 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · The Affiliated Hospital of Chengde Medical University · argenx · NCT06544499 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Affiliated Hospital of Chengde Medical University · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · Affiliated Hospital of Chengde Medical University · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199 CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
Phase 2 · West China Hospital of Sichuan University · West China Hospital · NCT06242418 Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NA · Chengde Medical College Affiliated Hospital · Harbin Medical University · NCT07567625 A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Phase 1/Phase 2 · Affiliated Hospital of Chengde Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06122831 A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery
Phase 4 · Affiliated Hospital of Chengde Medical University · Haisco Pharmaceutical Group Co., Ltd. · NCT06740201 A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Phase 3 · Affiliated Hospital of ChengDe Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06900920 ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Phase 3 · Affiliated Hospital of Chengde Medical University · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06775860 Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Phase 2/Phase 3 · Sichuan Provincial People's Hospital · Shanghai Xinzhi BioMed Co., Ltd. · NCT06111638 A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell
Phase 1 · The Affiliated Hospital of Chengde Medical College · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07179679 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colo
Phase 3 · Affiliated Hospital of Chengde Medical University · Seagen, a wholly owned subsidiary of Pfizer · NCT05253651 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants Wi
Phase 1/Phase 2 · Affiliated Hospital of Chengde Medical University · Shanghai Allink Biotherapeutics Co., Ltd. · NCT06656390 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Partici
Phase 3 · Investigational Site Number : 1560007 · Sanofi · NCT07086976 D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell L
Phase 3 · The Affiliated Hospital of Chengde Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300177 A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
Phase 1 · The Affiliated Hospital of Chengde Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06413953 Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
Phase N/A · Pingquan Hospital · Beijing Tiantan Hospital · NCT06429774 JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Phase 3 · Affiliated Hospital of Chengde Medical University · Jiangsu Alphamab Biopharmaceuticals Co., Ltd · NCT06079983 A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies
Phase 1/Phase 2 · Affiliated Hospital of Chengde Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07011186 A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate
Phase 2 · Affiliated Hospital of Chengde Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07551427 A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Phase 3 · Affiliated Hospital of Chengde Medical University · Hutchmed · NCT06387069

Look up another city

Look up another condition